July 2, 2014 by Arezu Sarvestani
The FDA outlines its vision for the 4 years ahead, generally staying the course on existing initiatives to improve regulatory efficiency, encourage innovation and ensure public health.
The FDA today revealed a draft version of its 4-year plan, laying out strategic priorities and goals for keeping patients and consumers safe while addressing industry concerns.
The agency highlighted 5 primary areas of concern: regulatory science, globalization, safety & quality, smart regulation and stewardship. Regulators plan to focus on these areas over the next 4 years in order to help speed innovations to market, provide the public with the best health information and ensure the security of regulated products.
